Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Comments on Juniper's (JNPR) Investor Day
-
Cantor Fitzgerald Starts Achaogen (AKAO) at Buy
-
Cantor Fitzgerald Starts Celsion Corp (CLSN) at Buy
-
Facebook (FB) PT Trimmed to $82 at Cantor Fitzgerald on Aggressive 2015 Investment Outlook
-
Cantor Fitzgerald Downgrades Apricus Biosciences (APRI) to Hold
-
Orchid Island Capital Announces Third Quarter 2014 Results
-
Cantor Fitzgerald Starts Rosetta Genomics (ROSG) at Hold
-
BGC Partners (BGCP) Commences $5.25/Share Tender for GFI Group (GFIG)
-
Apple (AAPL) PT Lifted to Street High $143 at Cantor Fitzgerald
-
Pre-Open Stock Movers 10/16: (EGLE) (IBIO) (MSO) (CHK) Higher; (NFLX) (EXTR) (TZOO) (BHI) Lower (more...)
-
Chimerix (CMRX) Price Target Raised to $39 at Cantor Fitzgerald
-
Streetinsider.com's Hot Lunchtime Reads 10/15: (LUV) (TSLA) (GALE) (SD)
-
Market Could Be Bottoming, Suggests Cantor Fitzgerald
-
Cantor Fitzgerald Comments on Apple (AAPL) Ahead of Thursday's Event
-
Cantor Fitzgerald Upgrades Endo Health (ENDP) to Hold
-
Netflix (NFLX): International Could Drive Upside in Q3 Subscriber Growth, Says Cantor
-
AutoGenomics (AGMX) Files $60M IPO
-
Radius Health (RDUS) Closes 3.13M Common Stock Offering for Net Proceeds of $53.3M
-
Notable Analyst Rating Changes 10/7: (IR) (ADHD) (AAPL) Upgraded; (SNSS) (DE) (CBSH) Downgraded
-
Cantor Fitzgerald Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Hold
-
Hewlett-Packard (HPQ) Price Target Raised to $39 at Cantor
-
BioTime (BTX) Announces 9.4M Common Registered Direct Offering; Will Price at $3.12/Share
-
Cantor Fitzgerald Analyt Comments on NewLink Genetics (NLNK) CFO Change
-
Radius Health (RDUS) Prices 2.75M Common Offering at $18.25/Share
-
Cantor Fitzgerald Upgrades Home Properties (HME) to Hold
-
UPDATE: Cantor Fitzgerald Upgrades UDR, Inc. (UDR) to Buy - Correct
-
eBay (EBAY) Buy Rating Reiterated at Cantor Fitzgerald
-
Quinpario Partners LLC Announces Filing of Registration Statement for Proposed Initial Public Offering of Units of Quinpario Acquisition Corp. 2
-
Market Wrap: Dow Slips Most Since July; OS Update, iPhone 6 Problems Hit Apple; GM Back to Investment Grade
-
#bendgate Fears Are Irrational, Says Wall Street Analyst (AAPL)
-
Merrimack (MACK) Buy Rating Reiterated at Cantor Fitzgerald
-
Energy XXI to Present at Johnson Rice Energy Conference
-
Apple (AAPL): 10 Million Weekend iPhone Sales Seen as 'Big Print' Given Supply Constraints, Says Cantor
-
Apple (AAPL): Cantor Sees Record Weekend Sales Despite iPhone 6 Plus Supply Constraints
-
Cantor Fitzgerald Starts Alibaba (BABA) at Buy
-
Cantor Fitzgerald Upgrades Cepheid (CPHD) to Buy
-
Corning (GLW) Investors Breath Sigh of Relief on iPhone, Says Cantor
-
Apple (AAPL): Profit Taking Could Prove Costly, Says Cantor
-
Apple Pay Could Force eBay to Spin-off PayPal, Says Cantor (EBAY)
-
Orchid Island Capital Announces September 2014 Monthly Dividend and August 29, 2014 RMBS Portfolio Characteristics
-
Unusual 11 Mid-Day Movers 9/9: (SCOK) (BNNY) (IPAS) Higher; (RADA) (GIGA) (LDOS) Lower
-
Notable Analyst Rating Changes 9/9: (GCA) (NEM) (DHI) Upgraded; (DKS) (POT) (MDC) Downgraded
-
Notable Mergers and Acquisitions of the Day 9/9: (GIS)/(BNNY) (BGCP)/(GFIG) (IPAS)
-
Pre-Open Stock Movers 9/9: (BNNY) (IPAS) (THLD) Higher; (FCEL) (FRAN) (PBY) Lower (more...)
-
BGC Partners (BGCP) to Commence $5.25/Share Tender for GFI Group (GFIG)
-
After-Hours Stock Movers 9/8: (BNNY) (IPAS) (CTIC) Higher; (PBY) (DOC) (PF) Lower (more...)
-
Cantor Fitzgerald Starts Merrimack Pharmaceuticals (MACK) at Buy
-
Cantor Fitzgerald Starts Chimerix (CMRX) at Buy
-
Cantor Fitzgerald Starts Tetraphase Pharmaceuticals (TTPH) at Buy
-
Cantor Fitzgerald Starts Endocyte (ECYT) at Buy

